Clinical Trial Update: Serotonin-norepinephrine Reuptake Inhibitor in Prophylaxis of Depression Following Fragility Fractures [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is evaluating a serotonin-norepinephrine reuptake inhibitor for preventing depression after fragility fractures in older adults; the st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Serotonin-norepinephrine reuptake inhibitor (SNRI)

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Depression in Old Age, Fragility Fracture | Phase 4 | Status: RECRUITING